Is APMLF or JNJ a better dividend investment in 2026?

APMLF currently yields 1727.12% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: APMLF offers higher current income.

What is the dividend yield difference between APMLF and JNJ?

APMLF has a forward dividend yield of 1727.12% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 1724.99 percentage points.

Home › Compare › APMLF vs JNJ

APMLF vs JNJ: Dividend Comparison 2026

APMLF yields 1727.12% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APMLF wins by $2553442967.66M in total portfolio value

INVESTMENT

TIME HORIZON10 years

APMLF

● Live price

1727.12%

Share price

$0.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2553442967.69M

Annual income

$2,292,348,870,295,133.00

Full APMLF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — APMLF vs JNJ

📍 APMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APMLF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APMLF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APMLF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APMLF

Annual income on $10K today (after 15% tax)

$146,804.84/yr

After 10yr DRIP, annual income (after tax)

$1,948,496,539,750,863.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, APMLF beats the other by $1,948,496,539,746,877.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APMLF + JNJ for your $10,000?

APMLF: 50%JNJ: 50%

100% JNJ50/50100% APMLF

Portfolio after 10yr

$1276721483.86M

Annual income

$1,146,174,435,149,911.20/yr

Blended yield

89.77%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

APMLF

No analyst data

Altman Z

-2.0

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APMLF buys

JNJ buys

No recent congressional trades found for APMLF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPMLFJNJ

Forward yield	1727.12% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$2553442967.69M ✓	$30.3K
Annual income after 10y	$2,292,348,870,295,133.00 ✓	$4,689.40
Total dividends collected	$2534685240.20M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: APMLF vs JNJ ($10,000, DRIP)

Year	APMLF Portfolio	APMLF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$183,412	$172,711.57	$10,592	$272.30	+$172.8K → APMLF
2	$3,156,746	$2,960,495.40	$11,289	$357.73	+$3.15M → APMLF
3	$50,998,167	$47,620,449.45	$12,123	$472.89	+$50.99M → APMLF
4	$773,561,058	$718,993,019.13	$13,141	$629.86	+$773.55M → APMLF
5	$11,020,215,127	$10,192,504,794.46	$14,408	$846.81	+$11020.20M → APMLF
6	$147,495,621,211	$135,703,991,025.44	$16,021	$1,151.60	+$147495.61M → APMLF
7	$1,855,273,859,446	$1,697,453,544,750.24	$18,122	$1,588.22	+$1855273.84M → APMLF
8	$21,939,742,634,017	$19,954,599,604,409.97	$20,930	$2,228.20	+$21939742.61M → APMLF
9	$244,013,175,133,284	$220,537,650,514,885.20	$24,792	$3,191.91	+$244013175.11M → APMLF
10	$2,553,442,967,687,747	$2,292,348,870,295,133.00	$30,274	$4,689.40	+$2553442967.66M → APMLF

APMLF vs JNJ: Complete Analysis 2026

APMLF — Stock

ApartmentLove Inc. operates multiple Internet listing services that promote residential homes, apartments, and vacation properties on behalf of property managers, apartment building owners and operators, and private landlords and hosts in United States, Canada, Mexico, and the Caribbean. It operates apartmentlove.com, an interactive real estate website that promotes housing, apartments, and other rental properties online; gottarent.com, a rental website; and ownerdirect.com, a vacation rental platform. The company was formerly known as Culada Asset Management, Inc. and changed its name to ApartmentLove Inc. in May 2018. ApartmentLove Inc. was incorporated in 2015 and is headquartered in Calgary, Canada.

Full APMLF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this APMLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APMLF vs SCHD APMLF vs JEPI APMLF vs O APMLF vs KO APMLF vs MAIN APMLF vs ABBV APMLF vs MRK APMLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.